Xencor (XNCR) Current Taxes (2016 - 2026)

Xencor (XNCR) reported Current Taxes of $841000.0 for Q1 2026, down 76.57% quarter-over-quarter from $3.6 million in Q4 2025.

Xencor (XNCR) Current Taxes (2016 - 2026) Analysis & Trends

Xencor (XNCR) has 8 years of Current Taxes data on file, last reported at $841000.0 in Q1 2026.

Current Taxes for Q1 2026 came in at $841000.0, changed N/A year-over-year; the trailing twelve-month figure through Mar 2026 was $841000.0 (changed N/A YoY), and the FY2025 annual result was $3.6 million, changed N/A from the prior year.
Current Taxes slipped to $841000.0 in Q1 2026 per XNCR's latest filing, from $3.6 million in the prior quarter.
Over five years, Current Taxes peaked at $5.3 million in Q4 2023 and troughed at $388000.0 in Q3 2022.
A 5-year average of $3.1 million and a median of $3.6 million in 2025 frame the typical range for Current Taxes.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Current Taxes (Qtr)
1	Alterity Therapeutics	925,601.88 Bn	925,601.85 Bn	-	10,460.56
2	Belite Bio	58,560.00 Bn	58,560.00 Bn	-	-
3	Quantum Biopharma	17,284.41 Bn	17,284.40 Bn	-	-
4	Legend Biotech	2,809.00 Bn	2,808.71 Bn	242.10 Mn	19.20 Mn
5	Evaxion A	1,334.43 Bn	1,334.42 Bn	-	-
6	Akari Therapeutics	1,312.27 Bn	1,312.26 Bn	-	-
7	Psyence Biomedical	212.16 Bn	212.16 Bn	-	-
8	Vertex Pharmaceuticals	114.83 Bn	107.58 Bn	2.59 Bn	-
9	Abivax	91.96 Bn	91.96 Bn	-	-
10	Xencor	953.38 Mn	878.64 Mn	-	841,000.00

Download Data